Department of Cardiology, Cardinal Wyszynski Hospital, Lublin, Poland.
Department of Biopharmacy, Medical University of Lublin, Lublin, Poland.
Curr Probl Cardiol. 2022 Jan;47(1):100874. doi: 10.1016/j.cpcardiol.2021.100874. Epub 2021 Apr 17.
Cardiac resynchronization therapy (CRT) is a well-established form of the treatment for heart failure (HF) in patients with left ventricle contraction dyssynchrony. Apart from typical in-office management, remote monitoring enables constant surveillance on both the patient's and the device's condition. This way, in case of any problems, clinical decisions could be made earlier leading to better outcome of CRT patients. COVID-19 pandemic with following lockdowns in many countries resulted in getting more attention on remote monitoring systems. The aim of this paper was to gather and summarize worldwide experiences from CRT remote monitoring during COVID-19 pandemic and point out future possibilities for HF patients treated with CRT. Already published experiences from remote monitoring of CRT devices during COVID-19 restrictions confirmed previous advantages of telemedical approach, however, more publications in this area would be helpful.
心脏再同步治疗(CRT)是治疗左心室收缩不同步心力衰竭(HF)患者的一种成熟方法。除了典型的门诊管理外,远程监测还可以对患者和设备的状况进行持续监测。这样,如果出现任何问题,可以更早地做出临床决策,从而改善 CRT 患者的预后。许多国家在 COVID-19 大流行期间实施封锁,这使得人们更多地关注远程监测系统。本文旨在收集和总结 COVID-19 大流行期间全球范围内 CRT 远程监测的经验,并指出 HF 患者接受 CRT 治疗的未来可能性。已经发表的关于 COVID-19 限制期间 CRT 设备远程监测的经验证实了远程医疗方法的先前优势,但在该领域有更多的出版物将是有益的。